Cue Biopharma, Inc. — Director's Dealing 2021

Dec 21, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cue Biopharma, Inc. (CUE)
CIK: 0001645460
Period of Report: 2021-12-20

Reporting Person: Pienta Kenneth (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-12-20	Stock Option (right to buy)	$11.45	A	80000	Acquired	2031-12-20	Common Stock (80000)	Direct

Footnotes

F1: This stock option grant becomes exercisable in four equal semi-annual installments beginning June 20, 2022.